Anna Maria Gerdina Pasmooij (A M G Pasmooij, Anna M G Pasmooij)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Highly Efficient

Top Venues

Clinical pharmacology and therapeutics

The British journal of dermatology

Journal of medical Internet research

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Maria Gerdina Pasmooij, Peter G M Mol, Jacob Cornelis Bot, Hubertus G Leufkens
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report. Clinical pharmacology and therapeutics 116 (1) (2024)
Anna Maria Gerdina Pasmooij, Peter G M Mol, Jacob Cornelis Bot, Hubertus G Leufkens
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report. Clinical pharmacology and therapeutics 116 (1) (2024)
Eva W H Korte, Anna Maria Gerdina Pasmooij, Marieke C Bolling, Sinéad Hickey, Sagair Hussain, Dimitra Kiritsi, Jan Kottner, Cecilia A C Prinsen, Angélique Sauvestre, Gaston Sendin, Phyllis I Spuls, Núria Tarrats, Verena Wally, Tobias Welponer, Martin Laimer, Peter C van den Akker, null null
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. The British journal of dermatology 191 (3) (2024)
Eva W H Korte, Anna Maria Gerdina Pasmooij, Marieke C Bolling, Sinéad Hickey, Sagair Hussain, Dimitra Kiritsi, Jan Kottner, Cecilia A C Prinsen, Angélique Sauvestre, Gaston Sendin, Phyllis I Spuls, Núria Tarrats, Verena Wally, Tobias Welponer, Martin Laimer, Peter C van den Akker, null null
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. The British journal of dermatology (2024)
Anna Maria Gerdina Pasmooij, Peter G M Mol, Jacob Cornelis Bot, Hubertus G Leufkens
The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report. Clinical pharmacology and therapeutics (2024)
Eva W H Korte, Phyllis I Spuls, Peter C van den Akker, Dimitra Kiritsi, Martin Laimer, Anna Maria Gerdina Pasmooij, Rainer Riedl, Elizabeth Vroom, Verena Wally, Tobias Welponer, Marieke C Bolling
Harmonization of outcomes in epidermolysis bullosa - report of the Core Outcome Sets for Epidermolysis Bullosa (COSEB) kick-off meeting. The British journal of dermatology (2023)
Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, Caspar van Loosen, Anna Maria Gerdina Pasmooij, Maaike van Dartel, Alfonsus J M van den Eertwegh, Anthonius de Boer, Michel W J M Wouters, Doranne Hilarius
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis. Journal of medical Internet research 24 (6) (2022)
Marko J Kallio, Viktoriia Starokozhko, Eleonora Agricola, Manja Burggraf, Anne Heß, Wolfgang Ballensiefen, Wiebke Löbker, Yoana Nuevo, Anna Maria Gerdina Pasmooij, Peter G M Mol, null null
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe. Clinical pharmacology and therapeutics (2022)
Audrey M M Hermans, Marc Maliepaard, Wouter P C Boon, Anna Maria Gerdina Pasmooij
Impact of the new European Union In Vitro Diagnostics Regulation on the practice of hospital diagnostic laboratories. Expert review of molecular diagnostics 22 (5) (2022)
Katerina M Mantila, Anna Maria Gerdina Pasmooij, Christine Erikstrup Hallgreen, Peter G M Mol, Job Frank Martien van Boven
Medication Adherence Measurement Methods in Registration Trials Supporting the Approval of New Medicines: A Cross-Sectional Analysis of Centralized Procedures in the European Union 2010-2020. Clinical pharmacology and therapeutics 112 (5) (2022)
Rosalie Baardman, V K Yenamandra, José C Duipmans, Anna Maria Gerdina Pasmooij, Marcel F Jonkman, Peter C van den Akker, Marieke C Bolling
Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed? Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2020)